Table A5.
Average score (0–4) for hypergranulation for untreated wounds, wounds treated with wild type L. reuteri R2LC or ILP100 in Cohort A and wounds treated with placebo or ILP100 wounds in Cohort B. For time points not included in the table, all wounds in all groups were scored as 0. * p < 0.05.
| Hypergranulation (Mean ± SEM) | ||||
|---|---|---|---|---|
| Cohort A | Day 7 | Day 9 | Day 11 | n;N |
| Untreated | 0.00 (± 0.00) | 0.17 (± 0.09) | 0.06 (± 0.06) | 3;18 |
| Wild type R2LC | 0.25 (± 0.13) | 0.17 (± 0.11) * | 0.00 (± 0.00) | 3;12 |
| ILP100 | 0.00 (± 0.00) | 0.00 (± 0.00) | 0.00 (± 0.00) | 6;30 |
| Cohort B | Day 7 | Day 9 | Day 11 | n;N |
| Placebo | 0.00 (±0.00) | 0.00 (±0.00) | 0.33 (±0.11) | 3;18 |
| ILP100 | 0.03 (±0.03) | 0.08 (±0.05) | 0.22 (±0.07) | 6;36 |